A Call To Prevent Inappropriate Prescribing of Fluoroquinolones from the European Medicines Agency and the European Association of Urology Guidelines Panel for Urological Infections
Paediatrics
A Call To Prevent Inappropriate Prescribing of Fluoroquinolones from the European Medicines Agency and the European Association of Urology Guidelines Panel for Urological Infections
Paediatrics

A Call To Prevent Inappropriate Prescribing of Fluoroquinolones from the European Medicines Agency and the European Association of Urology Guidelines Panel for Urological Infections

Eur Urol. 2025 Aug 13:S0302-2838(25)00432-4. doi: 10.1016/j.eururo.2025.07.015. Online ahead of print.

ABSTRACT

Despite EU-wide risk minimisation measures in March 2019 to prevent inappropriate prescribing of systemic and inhaled fluoroquinolones, pharmacovigilance evidence suggests that decreases in prescribing have been of limited magnitude. We renew the call to adhere to guidelines on appropriate prescribing of fluoroquinolones. We also advocate for proper patient counselling on the risks of serious adverse reactions to these antibiotics, including how to recognise the symptoms, to facilitate shared-decision making with patients.

PMID:40813209 | DOI:10.1016/j.eururo.2025.07.015